MiMedx

MiMedx

Yahoo Finance • 2 months ago

Mimedx expects $260M-$290M 2026 net sales amid $40M cost cuts and wound care reimbursement disruption

Earnings Call Insights: MiMedx Group (MDXG) Q1 2026 MANAGEMENT VIEW * “The start of the year has been an eventful one for MiMedx as we navigated the new reimbursement dynamics and continue to leverage growth opportunities for the compa... Full story

Yahoo Finance • 2 months ago

Northland Reaffirms Outperform Rating for MiMedx Group (MDXG)

MiMedx Group Inc. (NASDAQ:MDXG) is one of the 10 oversold small cap stocks to buy now. On April 17, Northland reduced the price target on MiMedx Group Inc. (NASDAQ:MDXG) from $10 to $6, which still results in an adjusted upside of more th... Full story

Yahoo Finance • 2 months ago

Catalyst Watch: Tesla talks AI5 chips, Intel reports, and the Warner Bros. deal goes to a vote

[Stock Exchange] ShinjiPhotographer Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - APRIL 20... Full story

Yahoo Finance • 2 months ago

MiMedx Expects Approx. $40 Mln Through Restructuring, Eliminates COO Position

(RTTNews) - MiMedx Group, Inc. (MDXG) Thursday announced elimination of the position of Chief Operating Officer, held by Ricci Whitlow and a series of cost reduction plans to save approximately $40 million. Further, the company now project... Full story

Yahoo Finance • 2 months ago

10 high-profitability small-cap stocks with lowest YTD performance in 2026

[Man looking at currency trading app on his smart phone from his home office] Alistair Berg A notable shift is underway in the small-cap market in 2026: profitable Russell 2000 companies are decisively outperforming their non-profitable c... Full story

Yahoo Finance • 4 months ago

MiMedx targets $340M–$360M 2026 revenue while navigating reimbursement changes and boosting surgical growth

Earnings Call Insights: MiMedx Group, Inc. (MDXG) Q4 2025 MANAGEMENT VIEW * CEO Joseph Capper stated, "In the fourth quarter of 2025, we once again exceeded our expectations, setting full year record highs for revenue and adjusted EBIT... Full story

Yahoo Finance • 4 months ago

Stem Cell and Regenerative Therapy Markets, 2022-2025 & Forecast to 2030 Featuring Profiles of Leading Companies - Gilead Sciences, Novartis, Bristol-Myers Squibb, Organogenesis, MiMedx Group and More

Company Logo Technological advances and growing investments in stem cell research by private entities and governments enhance therapeutic production while reducing costs, fueling market growth and adoption Stem Cell and Regenerative Ther... Full story

Yahoo Finance • 6 months ago

Organogenesis drops as Medicare to pull skin substitute LCDs (update)

[CMS] gustavofrazao Organogenesis (ORGO [https://seekingalpha.com/symbol/ORGO]) and MiMedx (MDXG [https://seekingalpha.com/symbol/MDXG]) traded lower on Friday after the Centers for Medicare & Medicaid Services (CMS) announced the withdra... Full story

Yahoo Finance • 8 months ago

MIMEDX Comments on CY 2026 Medicare Physician Fee Schedule Final Rule

MARIETTA, Ga., Nov. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today commented on the Centers for Medicare and Medicaid Services (“CMS”) release of the CY 2026 Physician Fee Schedule (“PFS”... Full story

Yahoo Finance • 8 months ago

MiMedx raises 2025 revenue growth outlook to mid- to high teens as company posts record quarterly sales

Earnings Call Insights: MiMedx Group, Inc. (MDXG) Q3 2025 MANAGEMENT VIEW * CEO Joseph Capper reported "our third quarter performance was outstanding across the enterprise, generating strong top line growth in both our Wound and Surgic... Full story

Yahoo Finance • 8 months ago

MIMEDX Announces Record Revenue for Third Quarter 2025

Second Consecutive Quarter of Highest Quarterly Net Sales in MIMEDX History Third Quarter Net Sales of $114 million Grew 35% Year-Over-Year Third Quarter GAAP Net Income and Diluted Earnings Per Share were $17 Million and $0.11, Respecti... Full story

Yahoo Finance • 8 months ago

MIMEDX to Host Third Quarter 2025 Operating and Financial Results Conference Call on October 29

MARIETTA, Ga., Oct. 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the third quarter ended September 30, 2025 after t... Full story

Yahoo Finance • 9 months ago

MIMEDX Announces Launch of EPIXPRESS®

MARIETTA, Ga., Oct. 06, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced the launch of EPIXPRESS®, the Company’s newest addition to its portfolio of AWC solutions. “I am pleased to a... Full story

Yahoo Finance • 10 months ago

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

MARIETTA, Ga., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced its schedule for the Symposium on Advanced Wound Care (SAWC) Fall meeting taking place September 3-6 in Las V... Full story

Yahoo Finance • 10 months ago

MIMEDX to Participate in Upcoming Investor Conferences

MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Cantor Global H... Full story

Yahoo Finance • 11 months ago

MiMedx raises full-year revenue growth outlook to low double digits as momentum builds post-record quarter

Earnings Call Insights: MiMedx Group, Inc. (MDXG) Q2 2025 MANAGEMENT VIEW * CEO Joseph H. Capper opened the call by highlighting the "exceptional performance" in Q2, reporting that "we grew our top line by 13%, generating the highest q... Full story

Yahoo Finance • 11 months ago

MIMEDX GROUP INC (NASDAQ:MDXG) Reports Record Q2 2025 Earnings, Surpassing Estimates and Driving Stock Surge

MIMEDX GROUP INC (NASDAQ:MDXG [https://www.chartmill.com/stock/quote/MDXG]) reported its second-quarter 2025 earnings, delivering record net sales and surpassing analyst expectations. The company’s performance has triggered a notable marke... Full story

Yahoo Finance • 11 months ago

Wednesday's after hours session: top gainers and losers

After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. [postmarket] GAINERS TICKER CHANGE COMMENT HTOOW [https://www.chartmill.com/st... Full story

Yahoo Finance • 11 months ago

MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results

Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06, Respectively Second Quarter Adjusted... Full story

Yahoo Finance • 11 months ago

Northland sees ‘key positive’ for MiMedx in CMS rule proposal

Northland analyst Carl Byrnes says the CMS is taking action to curb skin substitute spending with its 2026 physician fee schedule proposed rule released last night. The rule would eliminate separate selling prices and 6% reimbursement in p... Full story